Evidence map›Paper›PMID 35077513›Full record

ArticlePloS one2022

Pooling saliva samples as an excellent option to increase the surveillance for SARS-CoV-2 when re-opening community settings.

Joaquín Moreno-Contreras, Marco A Espinoza, Carlos Sandoval-Jaime, Marco A Cantú-Cuevas, Daniel A Madrid-González, Héctor Barón-Olivares, Oscar D Ortiz-Orozco, Asunción V Muñoz-Rangel, Cecilia Guzmán-Rodríguez, Manuel Hernández-de la Cruz and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Joaquín Moreno-ContrerasDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología UNAM, Cuernavaca, Morelos, México.
Marco A EspinozaDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología UNAM, Cuernavaca, Morelos, México.
Carlos Sandoval-JaimeDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología UNAM, Cuernavaca, Morelos, México.
Marco A Cantú-CuevasSecretaría de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Daniel A Madrid-GonzálezSecretaría de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Héctor Barón-OlivaresServicios de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Oscar D Ortiz-OrozcoServicios de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Asunción V Muñoz-RangelServicios de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Cecilia Guzmán-RodríguezServicios de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Manuel Hernández-de la CruzServicios de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
César M Eroza-OsorioServicios de Salud del Edo. de Morelos, Cuernavaca, Morelos, México.
Carlos F AriasDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología UNAM, Cuernavaca, Morelos, México.
Susana LópezDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología UNAM, Cuernavaca, Morelos, México.ORCID 0000-0001-6336-9209

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In many countries a second wave of infections caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has occurred, triggering a shortage of reagents needed for diagnosis and compromising the capacity of laboratory testing. There is an urgent need to develop methods to accelerate the diagnostic procedures. Pooling samples represents a strategy to overcome the shortage of reagents, since several samples can be tested using one reaction, significantly increasing the number and speed with which tests can be carried out. We have reported the feasibility to use a direct lysis procedure of saliva as source for RNA to SARS-CoV-2 genome detection by reverse transcription quantitative-PCR (RT-qPCR). Here, we show that the direct lysis of saliva pools, of either five or ten samples, does not compromise the detection of viral RNA. In addition, it is a sensitive, fast, and inexpensive method that can be used for massive screening, especially considering the proximity of the reincorporation of activities in universities, offices, and schools.

Indexed as

COVID-19COVID-19 Nucleic Acid TestingHumansMass ScreeningQuarantineSalivaSARS-CoV-2Sensitivity and Specificity

Identifiers

PMID35077513
PMCPMC8789121
OpenAlexW4206919109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.